No Data
Express News | 541 companies were surveyed by institutions, shenzhen mindray bio-medical electronics received the most attention.
Express News | The latest research route map of institutions has been released, with Shenzhen Mindray Bio-Medical Electronics receiving the most attention.
Zhejiang Crystal-Optech (002273): Multiple points of success in the optical track, layout of AR for rapid growth.
Zhejiang Crystal-Optech released the third quarter report for 2024: the company achieved revenue of 4.71 billion yuan for the first three quarters of 2024, a year-on-year increase of 32.69%; net income attributable to shareholders of the listed company was 0.862 billion yuan.
Zhejiang Crystal-Optech Co., Ltd Just Beat EPS By 25%: Here's What Analysts Think Will Happen Next
Zhejiang Crystal-Optech (002273): Q3 performance grows rapidly, optical high-end transformation accelerates.
Event: The company released the third quarter report of 2024, achieving a revenue of 2.055 billion yuan in the third quarter of 2024, a year-on-year increase of 21.19%; net income attributable to the parent company was 0.435 billion yuan, a year-on-year increase of 66.99%; after deducting non-recurring expenses.
Zhejiang Crystal-Optech (002273): Performance exceeds expectations with high growth driven by optical products of major customers.
Event: The company released the 3Q2024 financial report, achieving revenue of 4.71 billion yuan in the first three quarters, +32.69% year-on-year, achieving a net income attributable to the parent company of 0.862 billion yuan, +96.77% year-on-year, with a non-GAAP net income of 0.831 billion.
No Data
No Data